<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02781493</url>
  </required_header>
  <id_info>
    <org_study_id>2016SDU-QILU-06</org_study_id>
    <nct_id>NCT02781493</nct_id>
  </id_info>
  <brief_title>Efficacy of Prucalopride Plus Polyethylene Glycol in Bowel Preparation for Colonoscopy</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shandong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Binzhou People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tai'an People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Linyi People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shandong University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prucalopride based bowel cleansing regimen might be helpful to improve bowel cleansing
      quality before colonoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Colonoscopy is the standard approach for evaluating the colon currently. Thorough bowel
      cleansing is critical for adequate visualization of colonic mucosa during colonoscopy.
      Inadequate bowel cleansing results in adverse consequences for the examination, including
      lower adenoma detection rates, longer procedural time, lower cecal intubation rates, shorter
      intervals between examinations and an estimated 12-22% increase in overall colonoscopy
      cost.Unfortunately, despite advances in bowel preparation methods, up to one-third of all
      colonoscopies are reported to have an inadequate bowel preparation.

      Prucalopride can accelerate colonic transit and has been demonstrated to be efficient in
      constipation.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference of scores rating by Boston Bowel Preparation Scale between 2 groups.</measure>
    <time_frame>9 months</time_frame>
    <description>This is an established rating scale to evaluate the quality of bowel prep. The ratings will be compared between 2 groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Polyp detection rate between 2 groups.</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of adverse events between 2 groups.</measure>
    <time_frame>9 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Prucalopride Plus Polyethylene Glycol in Bowel Preparation for Colonoscopyp</condition>
  <arm_group>
    <arm_group_label>Prucalopride group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 mg Prucalopride plus 2 L Polyethylene Glycol regimen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>2 mg Placebo plus 2 L Polyethylene Glycol regimen</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2 mg Prucalopride plus 2 L Polyethylene Glycol regimen</intervention_name>
    <description>Patients enrolled in the Prucalopride group will recieve 2 mg Linaclotide plus 2 L Polyethylene Glycol regimen before colonoscopy.</description>
    <arm_group_label>Prucalopride group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2 mg Placebo plus 2 L Polyethylene Glycol regimen</intervention_name>
    <description>Patients enrolled in the Placebo group will recieve 2 mg Placebo plus 2 L Polyethylene Glycol regimen before colonoscopy.</description>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients 18 years of age or older,

          -  scheduled to undergo elective outpatient colonoscopy,

          -  and were able to provide informed consent.

        Exclusion Criteria:

          -  history of colorectal surgery

          -  severe colonic stricture or obstructing tumour

          -  dysphagia

          -  compromised swallowing reflex or mental status

          -  significant gastroparesis or gastric outlet obstruction

          -  known or suspected bowel obstruction or perforation

          -  severe chronic renal failure (creatinine clearance&lt;30 ml/min

          -  severe congestive heart failure (New York Heart Association class III or IV)

          -  uncontrolled hypertension (systolic blood pressure&gt;170 mm Hg, diastolic blood
             pressure&gt;100 mm Hg)

          -  dehydration

          -  disturbance of electrolytes

          -  pregnancy or lactation

          -  haemodynamically unstable

          -  unable to give informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Li Yanqing, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Qilu Hospital of Shandong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Li Yanqing, MD, PhD</last_name>
    <phone>86-531-82169236</phone>
    <email>liyanqing@sdu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Gastroenterology, Qilu Hospital, Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yanqing Li, MD, PhD</last_name>
      <phone>86-0531-82169236</phone>
      <email>liyanqing@sdu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2016</study_first_submitted>
  <study_first_submitted_qc>May 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2016</study_first_posted>
  <last_update_submitted>May 25, 2016</last_update_submitted>
  <last_update_submitted_qc>May 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Shandong University</investigator_affiliation>
    <investigator_full_name>Yanqing Li</investigator_full_name>
    <investigator_title>Vice president of Qilu Hospital</investigator_title>
  </responsible_party>
  <keyword>Prucalopride</keyword>
  <keyword>Polyethylene Glycol</keyword>
  <keyword>bowel preparation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

